Mosedipimod Uses, Dosage, Side Effects and more
Mosedipimod has been used in trials studying the supportive care and treatment of Chemotherapy-induced Neutropenia.
| Attribute | Details |
|---|---|
| Trade Name | Mosedipimod |
| Generic | Mosedipimod |
| Mosedipimod Other Names | Mosedipimod |
| Type | |
| Formula | C39H70O6 |
| Weight | Average: 634.983 Monoisotopic: 634.517239974 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
How Mosedipimod works
Mosedipimod is a proprietary compound originally derived from Sika deer antler. It accelerates endocytic trafficking of Pattern Recognition Receptors which allows for the swift removal of PAMPs/DAMPs. This drug has been shown to improve lung function and reduce inflammation and fibrosis in animal models. Currently, mosedipimod is being investigated against chemoradiation-induced oral mucositis and neutropenia, as well as against COVID-19.
